NAMSNewAmsterdam Pharma Company N.V.

$27.41

Who owns NAMS

167 institutions reported holding NAMS for 2026Q1, together 101% of the company, fewer than the 182 a quarter earlier.

167

Institutions reporting a position · as of 2026Q1 · down from 182 the quarter before

Shares held by institutions
122.6M

Shares held by institutions · 101% of the company · long US equity positions only, as reported on Form 13F

Reported value
$3.93B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
46%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
14
New positions
20
Positions exited
39
Added to
64
Reduced
46
Top 10 holdersof the company
65%
Institutional ownership by quarter, 2022Q4 to 2026Q1
QuarterFilersSharesReported value
2026Q1167122.6M$3.93B
2025Q4182118.3M$4.15B
2025Q3135120.6M$3.42B
2025Q2129116.2M$2.11B
2025Q1124111.1M$2.28B
2024Q412998.6M$2.53B
2024Q310077.1M$1.28B
2024Q29072.0M$1.38B
2024Q17672.2M$1.71B
2023Q43261.9M$691M
2023Q33550.2M$464M
2023Q22948.8M$581M
2023Q11933.3M$445M
2022Q41433.5M$362M
Largest reported holders, 2026Q1
HolderShares% of companyValue
Frazier Life Sciences Management, L.P.16.9M14%$542M
Capital World Investors11.1M9.1%$356M
RA CAPITAL MANAGEMENT, L.P.9.6M7.8%$306M
FCPM III SERVICES B.V.9.2M7.6%$294M
FMR LLC8.8M7.2%$281M
Bain Capital Life Sciences Investors, LLC7.3M6.0%$234M
WELLINGTON MANAGEMENT GROUP LLP5.1M4.2%$164M
DEERFIELD MANAGEMENT CO /NY4.3M3.5%$137M
VIKING GLOBAL INVESTORS LP4.2M3.5%$135M
Duquesne Family Office LLC3.1M2.5%$98M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…